SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039839
Filing Date
2023-05-15
Accepted
2023-05-15 16:31:42
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_aditxt.htm   iXBRL 10-Q 696559
2 CERTIFICATION f10q0323ex31-1_aditxt.htm EX-31.1 10535
3 CERTIFICATION f10q0323ex31-2_aditxt.htm EX-31.2 10537
4 CERTIFICATION f10q0323ex32-1_aditxt.htm EX-32.1 5058
  Complete submission text file 0001213900-23-039839.txt   4412673

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20230331.xsd EX-101.SCH 52093
6 XBRL CALCULATION FILE adtx-20230331_cal.xml EX-101.CAL 28128
7 XBRL DEFINITION FILE adtx-20230331_def.xml EX-101.DEF 231233
8 XBRL LABEL FILE adtx-20230331_lab.xml EX-101.LAB 484784
9 XBRL PRESENTATION FILE adtx-20230331_pre.xml EX-101.PRE 242147
54 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_aditxt_htm.xml XML 413944
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 23923199
SIC: 2834 Pharmaceutical Preparations